Transforming growth factor beta-1 (TGF-β1), an effective stimulator of fibroblasts, has a pathogenic effect on valvular heart disease and arrhythmias (Khan and Sheppard, 2006; Salvarani et al., 2017; Liu et al., 2019). Here, TGFB1 is linked to cardiac arrhythmia.